Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 23

Sort by

Sort Order Select

Journal Articles

Eltrombopag Plus Pulsed Dexamethasone As First Line Therapy for Subjects with Immune Thrombocytopenic Purpura (ITP)

Lunqing Zhang, Mingjie Zhang, Xin Du, MD, Yunfeng Cheng, MD PhD, Gregory Cheng, MD PhD

Blood (2018) 132 (Supplement 1): 733.

https://doi.org/10.1182/blood-2018-99-111584

Published: 2018

Journal Articles

Vemurafenib As First Treatment of Hairy Cell Leukemia

Gregory Cheng, Gym Cheng, MDPhD, Natalie Pui Ha Chan, Chris Wong, Raymond S Wong, MD

Blood (2014) 124 (21): 5482.

https://doi.org/10.1182/blood.V124.21.5482.5482

Published: 2014

Journal Articles

Randomized, Placebo-Controlled, Phase I/II Trial Of The Thrombopoietin Receptor Agonist Eltrombopag In Thrombocytopenic Patients With Advanced Myelodysplastic Syndromes Or Acute Myeloid Leukemia — A Subgroup Analysis Of Patients Receiving Concomitant Anticancer Therapy

Blood (2013) 122 (21): 5214.

https://doi.org/10.1182/blood.V122.21.5214.5214

Published: 2013

Journal Articles

Safety and efficacy of eltrombopag for treatment of chronic immune thrombocytopenia: results of the long-term, open-label EXTEND study

Mansoor N. Saleh, James B. Bussel, Gregory Cheng, Oliver Meyer, Christine K. Bailey, Michael Arning, Andres Brainsky

Blood (2013) 121 (3): 537–545.

https://doi.org/10.1182/blood-2012-04-425512

Published: 2013

Includes: Supplemental data

Journal Articles

Long-Term Safety and Efficacy of Eltrombopag in Adults with Chronic Immune Thrombocytopenia (ITP): Report of up to 5.5 Years of Treatment in EXTEND.

Mansoor N Saleh, MD, Gregory Cheng, James B Bussel, MD, Paul Burgess, Kalpana Bakshi, BS, MS, Andres Brainsky, MD, Christine K Bailey, PhD

Blood (2012) 120 (21): 2198.

https://doi.org/10.1182/blood.V120.21.2198.2198

Published: 2012

Journal Articles

Safety and prolonged activity of recombinant factor VIII Fc fusion protein in hemophilia A patients

Jerry S. Powell, Neil C. Josephson, Doris Quon, Margaret V. Ragni, Gregory Cheng, Ella Li, Haiyan Jiang, Lian Li, Jennifer A. Dumont, Jaya Goyal, Xin Zhang, Jurg Sommer, Justin McCue, Margaret Barbetti, Alvin Luk, Glenn F. Pierce

Blood (2012) 119 (13): 3031–3037.

https://doi.org/10.1182/blood-2011-09-382846

Published: 2012

Includes: Supplemental data

Journal Articles

Recombinant factor IX-Fc fusion protein (rFIXFc) demonstrates safety and prolonged activity in a phase 1/2a study in hemophilia B patients

Blood (2012) 119 (3): 666–672.

https://doi.org/10.1182/blood-2011-07-367003

Published: 2012

Includes: Supplemental data

Journal Articles

Safety and Efficacy of Extended Treatment with Eltrombopag in Adults with Chronic Immune Thrombocytopenia (ITP) From June 2006 to February 2011,

Mansoor N Saleh, MD, Gregory Cheng, MD, PhD, James B Bussel, MD, Paul Burgess, Lisa Marcello, BA, MS, Christine K Bailey, PhD, Andres Brainsky, MD

Blood (2011) 118 (21): 3296.

https://doi.org/10.1182/blood.V118.21.3296.3296

Published: 2011

Journal Articles

EXTEND Study Update: Safety and Efficacy of Eltrombopag In Adults with Chronic Immune Thrombocytopenia (ITP) From June 2006 to February 2010

Mansoor N. Saleh, MD, Gregory Cheng, MD, PhD, James B. Bussel, MD, Huiping Sun, Bhabita Mayer, MSc, Christine Bailey, PhD, Andres Brainsky, MD

Blood (2010) 116 (21): 67.

https://doi.org/10.1182/blood.V116.21.67.67

Published: 2010

Journal Articles

Incidence of Thromboembolic Events Across Eltrombopag Clinical Trials In Chronic Immune Thrombocytopenia (ITP)

James B. Bussel, MD, Gregory Cheng, MD, PhD, Mansoor N. Saleh, MD, Bhabita Mayer, MSc, Sandra Y. Vasey, MS, Andres Brainsky, MD

Blood (2010) 116 (21): 70.

https://doi.org/10.1182/blood.V116.21.70.70

Published: 2010

Journal Articles

Evaluation of Hepatobiliary Parameters During Eltrombopag Treatment in Patients with Chronic Immune Thrombocytopenic Purpura.

Willis C. Maddrey, Gregory Cheng, Abderrahim Khelif, Susan L Wroblewski, Andres Brainsky

Blood (2009) 114 (22): 2410.

https://doi.org/10.1182/blood.V114.22.2410.2410

Published: 2009

Journal Articles

Thromboembolic Events Observed in Eltrombopag Clinical Trials in Chronic Immune Thrombocytopenic Purpura.

James B. Bussel, MD, Gregory Cheng, Mansoor N. Saleh, MD, Sandra Vasey, Manuel Aivado, Andres Brainsky

Blood (2009) 114 (22): 2423.

https://doi.org/10.1182/blood.V114.22.2423.2423

Published: 2009

Journal Articles

Platelet Counts Following Eltrombopag Discontinuation in Patients with Chronic Immune Thrombocytopenic Purpura.

Gregory Cheng, Michael Tarantino, MD, Terry Gernsheimer, MD, Oliver Meyer, Andres Brainsky, Nicole L. Stone

Blood (2009) 114 (22): 3517.

https://doi.org/10.1182/blood.V114.22.3517.3517

Published: 2009

Journal Articles

Time to Splenectomy Failure in Patients with Recurrent or Refractory Chronic Immune Thrombocytopenic Purpura.

Gregory Cheng, Terry Gernsheimer, MD, Harold J. Olney, MD, CM, James B. Bussel, MD, Palvi Shah, Andres Brainsky, Kelly M. Grotzinger, Manuel Aivado

Blood (2009) 114 (22): 3522.

https://doi.org/10.1182/blood.V114.22.3522.3522

Published: 2009

Journal Articles

Long-Term Treatment of Chronic Immune Thrombocytopenic Purpura with Oral Eltrombopag: Results From the EXTEND Study.

Mansoor N. Saleh, MD, James B. Bussel, MD, Gregory Cheng, Balkis Meddeb, Bhabita Mayer, Christine Bailey, Manuel Aivado

Blood (2009) 114 (22): 682.

https://doi.org/10.1182/blood.V114.22.682.682

Published: 2009

Journal Articles

Oral Eltrombopag Treatment Reduces the Need for Concomitant Medications in Patients with Chronic Idiopathic Thrombocytopenic Purpura.

Patrick F. Fogarty, James B Bussel, Gregory Cheng, Mansoor N Saleh, Balkis Meddeb, Christine Bailey, Andres Brainsky

Blood (2008) 112 (11): 3424.

https://doi.org/10.1182/blood.V112.11.3424.3424

Published: 2008

Journal Articles

Eltrombopag Delivers Clinical Benefit in Chronic Idiopathic Thrombocytopenic Purpura (ITP) Patients Not Achieving Platelet Counts ≥50,000/μL - Data from the EXTEND Study.

Gregory Cheng, James B Bussel, Mansoor N Saleh, Balkis Meddeb, Maria E De Obaldia, Manuel Aivado, Nicole L Stone

Blood (2008) 112 (11): 3430.

https://doi.org/10.1182/blood.V112.11.3430.3430

Published: 2008

Journal Articles

Safety and Efficacy of Long-Term Treatment with Oral Eltrombopag for Chronic Idiopathic Thrombocytopenic Purpura.

James B Bussel, Gregory Cheng, Mansoor N Saleh, Balkis Meddeb, Christine Bailey, Nicole L Stone, Manuel Aivado

Blood (2008) 112 (11): 3432.

https://doi.org/10.1182/blood.V112.11.3432.3432

Published: 2008

Journal Articles

Oral Eltrombopag for the Long-Term Treatment of Patients with Chronic Idiopathic Thrombocytopenic Purpura: Results of a Phase III, Double- Blind, Placebo-Controlled Study (RAISE)

Gregory Cheng, Mansoor N Saleh, James B Bussel, Claus Marcher, Sandra Vasey, Bhabita Mayer, Manuel Aivado, Michael Arning, Nicole L. Stone

Blood (2008) 112 (11): 400.

https://doi.org/10.1182/blood.V112.11.400.400

Published: 2008

Journal Articles

Eltrombopag Is Efficacious in Patients with Refractory Chronic Idiopathic Thrombocytopenic Purpura (ITP) - Data from the EXTEND Study

Mansoor N Saleh, James B Bussel, Gregory Cheng, Balkis Meddeb, Paul M Burgess, Maria E De Obaldia, Nicole L Stone, Manuel Aivado

Blood (2008) 112 (11): 401.

https://doi.org/10.1182/blood.V112.11.401.401

Published: 2008

NARROW

Eltrombopag Plus Pulsed Dexamethasone As First Line Therapy for Subjects with Immune Thrombocytopenic Purpura (ITP)

Vemurafenib As First Treatment of Hairy Cell Leukemia

Randomized, Placebo-Controlled, Phase I/II Trial Of The Thrombopoietin Receptor Agonist Eltrombopag In Thrombocytopenic Patients With Advanced Myelodysplastic Syndromes Or Acute Myeloid Leukemia — A Subgroup Analysis Of Patients Receiving Concomitant Anticancer Therapy

Safety and efficacy of eltrombopag for treatment of chronic immune thrombocytopenia: results of the long-term, open-label EXTEND study

Long-Term Safety and Efficacy of Eltrombopag in Adults with Chronic Immune Thrombocytopenia (ITP): Report of up to 5.5 Years of Treatment in EXTEND.

Safety and prolonged activity of recombinant factor VIII Fc fusion protein in hemophilia A patients

Recombinant factor IX-Fc fusion protein (rFIXFc) demonstrates safety and prolonged activity in a phase 1/2a study in hemophilia B patients

Safety and Efficacy of Extended Treatment with Eltrombopag in Adults with Chronic Immune Thrombocytopenia (ITP) From June 2006 to February 2011,

EXTEND Study Update: Safety and Efficacy of Eltrombopag In Adults with Chronic Immune Thrombocytopenia (ITP) From June 2006 to February 2010

Incidence of Thromboembolic Events Across Eltrombopag Clinical Trials In Chronic Immune Thrombocytopenia (ITP)

Evaluation of Hepatobiliary Parameters During Eltrombopag Treatment in Patients with Chronic Immune Thrombocytopenic Purpura.

Thromboembolic Events Observed in Eltrombopag Clinical Trials in Chronic Immune Thrombocytopenic Purpura.

Platelet Counts Following Eltrombopag Discontinuation in Patients with Chronic Immune Thrombocytopenic Purpura.

Time to Splenectomy Failure in Patients with Recurrent or Refractory Chronic Immune Thrombocytopenic Purpura.

Long-Term Treatment of Chronic Immune Thrombocytopenic Purpura with Oral Eltrombopag: Results From the EXTEND Study.

Oral Eltrombopag Treatment Reduces the Need for Concomitant Medications in Patients with Chronic Idiopathic Thrombocytopenic Purpura.

Eltrombopag Delivers Clinical Benefit in Chronic Idiopathic Thrombocytopenic Purpura (ITP) Patients Not Achieving Platelet Counts ≥50,000/μL - Data from the EXTEND Study.

Safety and Efficacy of Long-Term Treatment with Oral Eltrombopag for Chronic Idiopathic Thrombocytopenic Purpura.

Oral Eltrombopag for the Long-Term Treatment of Patients with Chronic Idiopathic Thrombocytopenic Purpura: Results of a Phase III, Double- Blind, Placebo-Controlled Study (RAISE)

Eltrombopag Is Efficacious in Patients with Refractory Chronic Idiopathic Thrombocytopenic Purpura (ITP) - Data from the EXTEND Study

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only